Harbinger Research Publishes Coverage Initiation Report, on American Diversified Holdings Corporation (ADHC) and Its Operating Division, GlucoGuard
- Independent research coverage initiated by respected equity research firm
- Report includes comprehensive valuation analysis and multi-year financial forecasts
- Could facilitate future partnerships with financial institutions
- None.
Prepared by Brian R. Connell, CFA, the report offers an in-depth analysis of the Company's business, industry, and growth opportunities as well as an analysis of ADHC potential future value
Del Mar, California--(Newsfile Corp. - June 2, 2025) - Harbinger Research, LLC an independent equity research firm with a focus on the small cap and microcap stocks, announced today that it has published a new research report on American Diversified Holdings Corporation/GlucoGuard (OTC Pink: ADHC).
The report includes a valuation analysis, multi-year financial forecast model, and a value estimate of the Company and its shares.
To access the research report, please visit the Harbinger Research website at:
https://d1io3yog0oux5.cloudfront.net/harbingerresearch/media/fe6b5e637b3fa176ca427462ba6438f9.pdf
"This report will provide all interested stakeholders a comprehensive overview of ADHC's operations and a deep look into the potential of GlucoGuard's technology including a detailed valuation estimate," Commented ADHC. "This report will serve as the foundation to our future growth from highly respected Chartered Financial Analyst (CFA). As ADHC's growth propels the company into the major wall street arena this report with serve to open the door to high profile partnerships involving strategic partnerships with financial institutions focused on Mergers, Acquisitions and Corporate Finance." Concluded ADHC
About Harbinger Research, LLC
Harbinger Research, LLC is one of a new breed of issuer-sponsored research boutiques, providing unbiased equity research coverage to smaller issuers that cannot attract research coverage from traditional brokerage firm's research departments. Our mission is to help both investors and public issuers by improving the availability of issuer information and by providing sound, unbiased analysis of our issuer clients' businesses, industries, and current market valuation.
The policies of Harbinger Research, LLC require that all personnel strictly adhere to the CFA Institute's Code of Ethics and Standards of Professional Conduct, and its Best Practice Guidelines Governing Analyst / Corporate Issuer Relations. Please see www.cfainstitute.org for more information.
To view our disclosures and disclaimers, or for more information, visit www.harbingerresearch.com. Harbinger Research was compensated in the amount of
Harbinger Research, LLC Brian Connell, CFA Senior Research Analyst
ABOUT GLUCOGUARD
GlucoGuard, a Division of American Diversified Holdings Corporation is a patent-pending nocturnal glucose monitoring and delivery system for diabetic patients. The system helps prevent the dangerous effects of low blood sugar during sleep, including the potentially fatal "Death in Bed" phenomenon. Collaborating with a leading U.S. research university, a prominent biomedical engineering firm, and a major CGM company, GlucoGuard is at the forefront of diabetes management technology.
For more information, visit: www.GlucoGuardSleep.com. Contact: Phone: 817-525-0057
Email: info@GlucoGuardSleep.com
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7822/254131_81935201249818a5_001full.jpg
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7822/254131_81935201249818a5_002full.jpg
ABOUT AMERICAN DIVERSIFIED HOLDINGS CORPORATION
John Cacchioli, CEO American Diversified Holdings Corporation Telephone: (212) 537-5900
INVESTOR HOTLINE 858-325-7098Email: JC@American-Diversified.com
SOCIAL MEDIA TWITTER: @ADHCManagement. This Twitter page is the only official Twitter page for ADHC.
SAFE HARBOR FORWARD-LOOKING STATEMENTS: This press release may contain forward-looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/254131
FAQ
What is the significance of Harbinger Research's coverage initiation for ADHC stock?
Who authored the research report on American Diversified Holdings Corporation (ADHC)?
What does the Harbinger Research report on ADHC include?
How can investors access the Harbinger Research report on ADHC?
What is GlucoGuard in relation to ADHC?
